Last Price | 1.37 | Max Price | 2.92 |
Min Price | 1.37 | 1 Year return | -81.97 |
Sector | Consumer services | Subsector | Food & Drug Retailers |
Contact info:Country: France
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 35,327 | 2,942,594 | 1.20 % |
2020 | 32,526 | 3,186,643 | 1.02 % |
2021 | 31,070 | 3,567,649 | 0.87 % |
2022 | 34,021 | 1,932,573 | 1.76 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 6 percent. Over the period from December 2011 till December 2016 the stock rose on average 4 percent. Finatis's revenues between 2011 and 2015 were relatively steady and moved between 42,67 billion euros and 46,84 billion euros. Finatis's net results between 2011 and 2015 were far from constant and moved between 491,94 million euros and 303,2 million euros.
Finatis mainly operates in the food & drug sector. Over the past 10 years the global food & drug retailers gained around 32 percent. Measured since 2011 the sector is 27 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 32 percent.
The French company paid out dividends in the past 5 years. Over the past 5 years Finatis's dividend yield was at around 10 percent per year.
At the end of 2015 the French company had a balance sheet of 41,74 billion euros. Last year the total debt of the company was 31,42 billion euros. This equals around 75,26 percent of the total balance sheet.
At the end of 2015 the French company had around 5,65 million stocks listed on the exchanges.
All Finatis's annual reports can be found here. More information about Finatis can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
46,841
|
36,788
|
38,642
|
38,039
|
35,327
|
32,526
|
Costs |
46,912
|
36,166
|
38,706
|
38,216
|
35,882
|
32,712
|
Profit |
-71
|
622
|
-64
|
-177
|
-555
|
-186
|
Margin of profit |
-0.15
|
1.69
|
-0.17
|
-0.47
|
-1.57
|
-0.57
|
ROI |
-0.69
|
88.48
|
-14.41
|
-96.20
|
136.03
|
24.77
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
10,327
|
703
|
444
|
184
|
-408
|
-751
|
Debt |
31,415
|
43,096
|
44,724
|
44,899
|
38,162
|
32,860
|
Total assets |
41,742
|
43,799
|
45,168
|
45,083
|
37,754
|
32,109
|
Solvency |
24.74
|
1.61
|
0.98
|
0.41
|
-1.08
|
-2.34
|
Cash |
5,132
|
5,938
|
3,581
|
4,128
|
3,680
|
2,815
|
Cashflow |
2,868
|
1,638
|
1,026
|
1,205
|
1,158
|
1,705
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.09
|
0.04
|
0.02
|
0.03
|
0.03
|
0.05
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
52.50
|
49.50
|
52.48
|
42.20
|
26.80
|
Eps |
110.06
|
-11.33
|
-31.35
|
-98.34
|
-32.96
|
Price/earnings-ratio |
0.48
|
-4.37
|
-1.67
|
-0.43
|
-0.04
|
Dividend |
2.00
|
2.00
|
2.00
|
0.0
|
|
Dividend % |
3.81 %
|
4.04 %
|
3.81 %
|
0.00 %
|
|
Payout % |
0.02
|
-0.18
|
-0.06
|
0.0
|
|
Book value |
124.42
|
78.61
|
32.60
|
-72.30
|
-133.08
|
Market to book |
2.37
|
1.59
|
0.62
|
-1.71
|
-97.14
|
Cashflow per stock |
289.89
|
181.64
|
213.47
|
205.21
|
302.14
|
Stocks |
6
|
6
|
6
|
6
|
6
|
Market Cap |
296.65
|
279.60
|
296.25
|
238.14
|
7.73
|
Date
|
Price
|
---|---|
17 Dec 2024
|
1.37
|
10 Dec 2024
|
1.37
|
06 Dec 2024
|
1.37
|
03 Dec 2024
|
1.37
|
29 Nov 2024
|
1.37
|
27 Nov 2024
|
1.37
|
13 Nov 2024
|
1.37
|
08 Nov 2024
|
1.37
|
05 Nov 2024
|
1.37
|
31 Oct 2024
|
1.37
|
29 Oct 2024
|
1.37
|
23 Oct 2024
|
1.37
|
19 Oct 2024
|
1.37
|
16 Oct 2024
|
1.37
|
14 Oct 2024
|
1.37
|
05 Oct 2024
|
1.37
|
02 Oct 2024
|
1.37
|
27 Sep 2024
|
1.37
|
20 Sep 2024
|
1.37
|
17 Sep 2024
|
1.37
|
13 Sep 2024
|
1.37
|
28 Aug 2024
|
1.37
|
26 Aug 2024
|
1.37
|
23 Aug 2024
|
1.37
|
11 Aug 2024
|
1.37
|
07 Aug 2024
|
1.37
|
05 Aug 2024
|
1.37
|
01 Aug 2024
|
1.37
|
30 Jul 2024
|
1.37
|
26 Jul 2024
|
1.37
|